ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Blumberg, Comis, Skalka Named Fox Chase VPs; Howard Temin Appointed To NCAB

June 5, 1987

ACS Elects New Volunteer Leaders

November 19, 2010

Budget Projections for 1978 Offer Clues On Research NCI Hopes To Fund

June 18, 1976

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

NCAB Oks Organ Systems Plan, Criteria For Starting, Ending Working Groups

October 7, 1988

In Brief: New San Antonio Center Wins Core Grants; ASCO forming A Technology Assessment Committee

July 19, 1991